These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8063410)

  • 1. Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.
    Arditi M; Zhou J; Huang SH; Luckett PM; Marra MN; Kim KS
    Infect Immun; 1994 Sep; 62(9):3930-6. PubMed ID: 8063410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CD14, LBP and BPI in the monocyte response to LPS of different polysaccharide chain length.
    Jahr TG; Sundan A; Lichenstein HS; Espevik T
    Scand J Immunol; 1995 Jul; 42(1):119-27. PubMed ID: 7543211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
    Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW
    J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
    Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two monoclonal antibodies directed against bactericidal/permeability-increasing protein.
    Dentener MA; Smit FT; Francot GJ; Buurman WA
    J Infect Dis; 1994 Dec; 170(6):1483-9. PubMed ID: 7995988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal/permeability-increasing protein release in whole blood ex vivo: strong induction by lipopolysaccharide and tumor necrosis factor-alpha.
    Dentener MA; Francot GJ; Hiemstra PS; Tool AT; Verhoeven AJ; Vandenabeele P; Buurman WA
    J Infect Dis; 1997 Jan; 175(1):108-17. PubMed ID: 8985203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes.
    Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP
    J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.
    Marra MN; Thornton MB; Snable JL; Leong S; Lane J; Wilde CG; Scott RW
    Blood Purif; 1993; 11(2):134-40. PubMed ID: 7506040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal/permeability-increasing protein inhibits endotoxin-induced vascular nitric oxide synthesis.
    Ciornei CD; Egesten A; Engström M; Törnebrandt K; Bodelsson M
    Acta Anaesthesiol Scand; 2002 Oct; 46(9):1111-8. PubMed ID: 12366506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
    Mészáros K; Parent JB; Gazzano-Santoro H; Little R; Horwitz A; Parsons T; Theofan G; Grinna L; Weickmann J; Elsbach P
    J Leukoc Biol; 1993 Dec; 54(6):558-63. PubMed ID: 8245707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
    J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI.
    Rogy MA; Moldawer LL; Oldenburg HS; Thompson WA; Montegut WJ; Stackpole SA; Kumar A; Palladino MA; Marra MN; Lowry SF
    Ann Surg; 1994 Jul; 220(1):77-85. PubMed ID: 8024362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
    Elsbach P
    Ciba Found Symp; 1994; 186():176-87; discussion 187-9. PubMed ID: 7768151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation.
    Wilde CG; Seilhamer JJ; McGrogan M; Ashton N; Snable JL; Lane JC; Leong SR; Thornton MB; Miller KL; Scott RW
    J Biol Chem; 1994 Jul; 269(26):17411-6. PubMed ID: 7517398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
    Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
    Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.